Regulon

Regulon: R-3029

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
72.99043120Pr-28Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5329 ENSG00000011422 PLAUR Q03405
5054 ENSG00000106366 SERPINE1 P05121
1075 ENSG00000109861 CTSC P53634
83442 ENSG00000142669 SH3BGRL3 Q9H299
11098 ENSG00000150687 PRSS23 O95084
3678 ENSG00000161638 ITGA5 P08648
3489 ENSG00000167779 IGFBP6 A0A3B3IUE0

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ATN-161ITGB3ProteinANTAGONISTIntegrin alpha-5/beta-1 antagonist20
ALEPLASININSERPINE1Small moleculeINHIBITORPlasminogen activator inhibitor-1 inhibitor10
BRENSOCATIBCTSCSmall moleculeINHIBITORDipeptidyl peptidase I inhibitor30
PF-04605412ITGA5AntibodyINHIBITORFibronectin receptor alpha inhibitor10
VOLOCIXIMABITGB1AntibodyANTAGONISTIntegrin alpha-5/beta-1 antagonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3029

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-01975PCDH9down-regulatesELF4activatesR-3029205Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-03406CCDC60down-regulatesELF4activatesR-3029201Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-07032ATRXdown-regulatesELF4activatesR-30292011Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-07722TRPM2down-regulatesELF4activatesR-3029202Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-09280RP1down-regulatesELF4activatesR-3029208Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-12336GPR98down-regulatesELF4activatesR-30292010Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-13842ADAMTS8down-regulatesELF4activatesR-3029204Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-15054PTENup-regulatesELF4activatesR-3029202Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-19491NF1up-regulatesELF4activatesR-30292014Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-21068KRTAP4-7up-regulatesELF4activatesR-3029208Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-21700MUC17up-regulatesELF4activatesR-3029209Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-22761IDH1down-regulatesELF4activatesR-30292011Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-23084PDHA2down-regulatesELF4activatesR-3029202Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-24875NSUN5down-regulatesELF4activatesR-3029205Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-28740SYN3down-regulatesELF4activatesR-3029201Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-34535RBPJLdown-regulateshsa-mir-328repressesR-3029279Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-34957ADAMTS19up-regulateshsa-mir-328repressesR-30292710Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-37858PRKCDup-regulateshsa-mir-328repressesR-30292722Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-38032PTENdown-regulateshsa-mir-328repressesR-30292710Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB

CMF-43278POLRMTdown-regulateshsa-mir-328repressesR-30292711Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ATN-161, ALEPLASININ, BRENSOCATIB, PF-04605412, VOLOCIXIMAB